Full-Time

Associate Director

Clinical Program Management

Posted on 10/30/2024

Eikon Therapeutics

Eikon Therapeutics

201-500 employees

Biotech startup developing innovative medicines

Biotechnology
Healthcare

Compensation Overview

$174k - $190kAnnually

+ Bonus + Equity Compensation

Senior

New York, NY, USA + 1 more

More locations: Hayward, CA, USA

Requires onsite presence in California, New York, or New Jersey for a minimum of 3 days a week.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • 10+ years of experience with a Bachelor's degree, or 8+ years with a post graduate degree
  • In-depth knowledge of ICH-GCP, EMEA guidelines and other relevant regulations and guidelines.
  • Proven ability to manage clinical studies within timelines and budgets while maintaining high quality standards and patient safety
  • Ability to proactively develop risk management and mitigation plans in country and resolve issues locally
  • Effective and efficient time management, organizational and interpersonal skills, conflict management and problem-solving skills
  • High sense of accountability and urgency in order to prioritize deliverables
  • Strong communication skills and negotiation skills as well as excellent influencing and training/mentoring, both written and verbal
  • Ability to focus on multiple deliverables and protocols simultaneously is essential
  • Positive mindset, growth mindset, capable of working independently and being self-driven
  • Able to directly influence Clinical Operations staff.
  • Fully Vaccinated with one of the FDA approved COVID-19 vaccines
Responsibilities
  • Team leader and builder, who manages trial deliverables, timelines in assigned protocols to meet country commitments
  • Responsible for quality and compliance in assigned protocols
  • Works with minimal oversight from Clinical Operations Senior Director or Director, in collaboration with Clinical Operations teams, and Clinical Research and Development functional teams
  • Works with finance, legal, external vendors and clinical sites to ensure country deliverables are obtained for submissions, budgets, regulatory and local milestones
  • Collaborates closely with Regulatory and Clinical Operations to align on country timelines
  • Provides support and oversight to local vendors as applicable
  • Oversight and coordination of local processes, clinical and ancillary supplies management, importing and exporting requirements, supplies destruction, local electronic/hard copy filing, archiving and retention requirements (in collaboration with TMF Operations team), insurance process management
  • Enter and update country information in clinical, regulatory, safety and finance systems
  • Contribute or lead initiatives and projects adding value to the enterprise, as required
  • Ensure that clinical studies are conducted in accordance with approved protocols, ICH-GCP, EMEA, PMDA and other relevant regulations and guidelines.

Eikon Therapeutics focuses on discovering and developing new medicines in the pharmaceutical industry. The company employs advanced technologies to study biological systems, aiming to identify new drug targets by examining the dynamic aspects of biology rather than just static chemical processes. Their team consists of diverse professionals, including data scientists, chemists, and engineers, which allows them to combine science and engineering to create new therapies that improve and extend life. A key feature of their approach is a proprietary single-molecule tracking (SMT) platform that visualizes protein motion in living cells, enabling precise inventory of molecular interactions. Eikon Therapeutics aims to serve patients with serious diseases by developing effective treatments and generates revenue through the commercialization of these therapies.

Company Stage

Series C

Total Funding

$750.8M

Headquarters

Hayward, California

Founded

2019

Growth & Insights
Headcount

6 month growth

7%

1 year growth

14%

2 year growth

62%
Simplify Jobs

Simplify's Take

What believers are saying

  • Eikon's recent acquisition of global rights to clinical-stage assets and a robust drug development pipeline positions it for significant growth and market impact.
  • The company's strategic partnerships, such as with Impact Therapeutics for PARP1 selective inhibitors, enhance its capabilities in developing targeted cancer therapies.
  • Eikon's expansion into a new 36,284-square-foot office space in Jersey City reflects its growth and commitment to scaling operations.

What critics are saying

  • The highly competitive biotech and pharmaceutical sectors require continuous innovation to maintain a competitive edge.
  • The integration of newly acquired assets and technologies may pose challenges in terms of operational alignment and resource allocation.

What makes Eikon Therapeutics unique

  • Eikon Therapeutics leverages proprietary single-molecule tracking (SMT) technology to visualize protein motion in living cells, setting it apart from competitors who rely on static snapshots of chemical processes.
  • The integration of advanced automation and artificial intelligence allows Eikon to inventory molecular interactions with unprecedented scale and precision.
  • Eikon's diverse team of scientists, engineers, and clinicians enables a multidisciplinary approach to drug development, enhancing innovation and problem-solving capabilities.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE